Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen M Mowry

Showing results (71-80 of 163) with videos related to

Pageof 17
Sort By:
Annals of Neurology|September 19, 2025
Fasting Mimicking Diets Reverse Accelerated Biological Aging in Multiple SclerosisFatemeh Siavoshi, Matthew D Smith, Sandra Cassard, et al.
Contemporary Clinical Trials|October 1, 2022
N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trialVinicius A Schoeps, Jennifer S Graves, William A Stern, et al.
Ethnicity & Disease|June 8, 2026
The Interplay of Neighborhood Deprivation, Race, and Multiple SclerosisJagriti Jackie Bhattarai, Kavya Bhattiprolu, Miranda R Jones, et al.
Neurology|November 16, 2018
Body mass index, but not vitamin D status, is associated with brain volume change in MSEllen M Mowry, Christina J Azevedo, Charles E McCulloch, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 17, 2015
Gut microbiota in multiple sclerosis: possible influence of immunomodulatorsBrandi L Cantarel, Emmanuelle Waubant, Christel Chehoud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 17, 2025
Frequency and potential risk factors associated with the development of asymptomatic T2 hyperintense cervical spine lesions on MRI in patients with relapsing-remitting multiple sclerosisYasser Fadlallah, Yujie Wang, Muhammad Taimur Malik, et al.
Journal of Rehabilitation and Assistive Technologies Engineering|January 24, 2022
Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosisJennifer L Keller, Fan Tian, Kathryn C Fitzgerald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 19, 2025
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controlsAndrea Salazar-Camelo, Lauren Vega, Yasser Fadlallah, et al.
Multiple Sclerosis and Related Disorders|February 14, 2022
Type of serum collection tube does not impact neurofilament light chain levelsElias S Sotirchos, Kathryn C Fitzgerald, Matthew D Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple SclerosisMingjing Chen, Rose Noroozi, Matthew D Smith, et al.
Pageof 17

Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Annals of Neurology|September 19, 2025
Fasting Mimicking Diets Reverse Accelerated Biological Aging in Multiple SclerosisFatemeh Siavoshi, Matthew D Smith, Sandra Cassard, et al.
Contemporary Clinical Trials|October 1, 2022
N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trialVinicius A Schoeps, Jennifer S Graves, William A Stern, et al.
Ethnicity & Disease|June 8, 2026
The Interplay of Neighborhood Deprivation, Race, and Multiple SclerosisJagriti Jackie Bhattarai, Kavya Bhattiprolu, Miranda R Jones, et al.
Neurology|November 16, 2018
Body mass index, but not vitamin D status, is associated with brain volume change in MSEllen M Mowry, Christina J Azevedo, Charles E McCulloch, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 17, 2015
Gut microbiota in multiple sclerosis: possible influence of immunomodulatorsBrandi L Cantarel, Emmanuelle Waubant, Christel Chehoud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 17, 2025
Frequency and potential risk factors associated with the development of asymptomatic T2 hyperintense cervical spine lesions on MRI in patients with relapsing-remitting multiple sclerosisYasser Fadlallah, Yujie Wang, Muhammad Taimur Malik, et al.
Journal of Rehabilitation and Assistive Technologies Engineering|January 24, 2022
Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosisJennifer L Keller, Fan Tian, Kathryn C Fitzgerald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 19, 2025
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controlsAndrea Salazar-Camelo, Lauren Vega, Yasser Fadlallah, et al.
Multiple Sclerosis and Related Disorders|February 14, 2022
Type of serum collection tube does not impact neurofilament light chain levelsElias S Sotirchos, Kathryn C Fitzgerald, Matthew D Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple SclerosisMingjing Chen, Rose Noroozi, Matthew D Smith, et al.
Pageof 17